A pharmaceutical formulation of the 5HT1-agonist, zolmitriptan, for use in intranasal administration. The formulation is useful in treating migraine and related disorders.
申请公布号
WO0139772(A1)
申请公布日期
2001.06.07
申请号
WO2000GB04528
申请日期
2000.11.28
申请人
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;DEARN, ALAN, ROY;WILLIAMSON, SARAH, LOUISE;SUMMERS, SIMON, JOHN;COOMBER, TREVOR, JOHN
发明人
DEARN, ALAN, ROY;WILLIAMSON, SARAH, LOUISE;SUMMERS, SIMON, JOHN;COOMBER, TREVOR, JOHN
